Apyx Medical (APYX) Shares Outstanding (2010 - 2026)

Apyx Medical has reported Shares Outstanding for 17 years, with the latest figure at $41.9 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 10.78% year-over-year to $41.9 million; the trailing twelve-month figure through Mar 2026 stood at $41.9 million (up 10.78% YoY), and the FY2025 full-year result was $41.8 million, up 10.56% from the prior year.
• Shares Outstanding for Q1 2026 stood at $41.9 million, roughly flat from $41.8 million in the prior quarter.
• The five-year high for Shares Outstanding was $41.9 million in Q1 2026, with the low at $34.5 million in Q1 2022.
• Historically, Shares Outstanding has averaged $36.2 million across 5 years, with a median of $34.6 million in 2023.
• Annual changes were most pronounced in 2024 — Shares Outstanding changed 0.0% — and 2026, when it grew 10.78%.
• Apyx Medical's Shares Outstanding stood at $34.6 million in 2022, then increased by 0.13% to $34.6 million in 2023, then grew by 9.09% to $37.8 million in 2024, then gained by 10.56% to $41.8 million in 2025, then grew by 0.2% to $41.9 million in 2026.
• The last three Shares Outstanding figures came in at $41.9 million (Q1 2026), $41.8 million (Q4 2025), and $37.8 million (Q3 2025), per Business Quant data.